Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
GSE27831 Resource Report Resource Website 10+ mentions |
GSE27831 (RRID:SCR_003646) | data or information resource, data set | Curated data set from gene expression profiles of 29 unique samples from uveal melanoma patients that were measured on Affymetrix microarray. In addition, expression of syntenin-1 was measured by RT-PCR and this data is also available in the study. | syntenin-1, gene expression profile, gene expression, eye, adult human |
is related to: Gene Expression Omnibus has parent organization: RanchoBiosciences |
Cancer, Uveal melanoma | Free, Public | nlx_157798 | SCR_003646 | SciCrunch Registry | 2026-10-17 01:34:53 | 13 | ||||||||
|
GSE20194 Resource Report Resource Website 50+ mentions |
GSE20194 (RRID:SCR_003645) | GSE20194 | data or information resource, data set | Curated data set of gene expression data from 230 stage I-III breast cancers that were generated from fine needle aspiration specimens of newly diagnosed breast cancers before any therapy. The biopsy specimens were collected sequentially during a prospective pharmacogenomic marker discovery study between 2000 and 2008. These specimens represent 70-90% pure neoplastic cells with minimal stromal contamination. In the study, patients received 6 months of preoperative (neoadjuvant) chemotherapy including paclitaxel, 5-fluorouracil, cyclophosphamide and doxorubicin followed by surgical resection of the cancer. | gene expression, chemotherapy, paclitaxel, 5-fluorouracil, cyclophosphamide, doxorubicin, adult human |
is related to: Gene Expression Omnibus has parent organization: RanchoBiosciences |
Cancer, Breast cancer | Free, Public | nlx_157797 | SCR_003645 | SciCrunch Registry | 2026-10-17 01:36:27 | 70 | |||||||
|
GSE4698 Resource Report Resource Website 1+ mentions |
GSE4698 (RRID:SCR_003644) | GSE4698 | data or information resource, data set | Curated data set where gene expression profiling was performed on 60 prospectively collected samples of children with first relapse of acute lymphoblastic leukemia enrolled on the relapse trial ALL-REZ BFM 2002 of the Berlin-Frankfurt-Muenster study group. | young human, gene expression, relapse, male, female, gene expression profile, child |
is related to: Gene Expression Omnibus has parent organization: RanchoBiosciences |
Cancer, Acute lymphoblastic leukemia | Free, Public | nlx_157795 | SCR_003644 | SciCrunch Registry | 2026-10-17 01:34:47 | 4 | |||||||
|
GSE4271 Resource Report Resource Website 50+ mentions |
GSE4271 (RRID:SCR_003643) | GSE4271 | data or information resource, data set | Curated data set from a study that investigated 77 primary high-grade astrocytomas and 23 matched recurrences so that changes in gene expression related to both survival and disease progression can be identified. Samples in the study include WHO grade III and IV astrocytomas with a wide range of survival times. | adult human, brain, gene expression |
is related to: Gene Expression Omnibus has parent organization: RanchoBiosciences |
Cancer, Astrocytoma | Free, Public | nlx_157794 | SCR_003643 | SciCrunch Registry | 2026-10-17 01:35:24 | 62 | |||||||
|
Target genes of Wnt/beta-catenin signaling Resource Report Resource Website 10+ mentions |
Target genes of Wnt/beta-catenin signaling (RRID:SCR_007022) | Target genes of Wnt/beta-catenin signaling | data or information resource, data set | A list of target genes of Wnt/beta-catenin signaling. Suggestions for additions are welcome. Direct targets are defined as those with Tcf binding sites and demonstrating that these sites are important. | target gene, wnt/beta-catenin signaling, wnt, beta-catenin, signaling, gene | has parent organization: Stanford University; Stanford; California | Colon cancer, Tumor, Adenocarcinoma, Melanoma, Cancer | The community can contribute to this resource | nlx_156867 | SCR_007022 | SciCrunch Registry | 2026-10-17 01:34:59 | 24 | |||||||
|
UMAS University Hospital - Biobanks of the Department of Clinical Pathology and Cytology Resource Report Resource Website |
UMAS University Hospital - Biobanks of the Department of Clinical Pathology and Cytology (RRID:SCR_005957) | Biobanks of the Department of Clinical Pathology and Cytology | instrument supplier, material resource | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on October 6th, 2022. The biobank comprises paraffin blocks of surgical and autopsy tissue samples and corresponding histological slides as well as cytological material consisting of slides of vaginal smears, fine needle aspiration biopsies and exfoliative cytological material. The tissue samples date back until 1944 and most of the cytological samples until 1970. A subunit of the bank constitutes the National Tissue Microarray Centre. This center is supported by SWEGENE with the purpose to organize and construct tissue microarrays (TMA:s) for high throughput molecular pathology research on various kinds of tumors and other diseases. By linking the TMA.s to long-term and complete clinical follow-up data, prognostic and predictive studies will be facilitated. Biobank content: * Approximately 2,4 million paraffin blocks of surgical tissue specimens, * 1,1 million paraffin blocks of tissue samples from autopsies, * 3,8 million histological slides and * 1,6 million cytology slides. At present, the Tissue Microarray Centre includes: * A consecutive series of all invasive breast cancers (n=600) diagnosed in Malmo between 1988 and 1992. * All incident breast cancers within the Malmo Diet and Cancer cohort (n=400). * A subgroup of 600 pre-menopausal primary breast cancers within the nationwide, population-based randomized tamoxifen trial SBII:2. * 180 primary breast cancers from post-menopausal women included in a similar study. * A set of 120 extremely well characterized primary breast cancer samples with a clinical follow-up of 10 years. More than 40 relevant tumor biological parameters have been recorded in this material and it is therefore useful for a first screening of a marker in order to identify associations to other gene products. * 350 renal cell carcinomas (In collaboration with NUS). We provide researchers with state-of-the-art population based tissue microarrays with long-term and complete follow-up data on survival and treatment. With the TMA-technology, valuable biobank material will be preserved, allowing high throughput in-situ analyses of various tumors and other diseases with a minimal waste of tissue. | surgery, autopsy, histology slide, vaginal smear, fine needle aspiration, biopsy, tissue microarray, tumor, disease, cancer, diet, renal cell, kidney |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Swedish National Biobank Program |
Breast cancer, Cancer, Tumor, Carcinoma | SWEGENE | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_151315 | SCR_005957 | SciCrunch Registry | UMAS University Hospital - Biobanks of the Department of Clinical Pathology Cytology | 2026-10-17 01:35:27 | 0 | |||||
|
UK DNA Banking Network Resource Report Resource Website 1+ mentions |
UK DNA Banking Network (RRID:SCR_010619) | UDBN | biomaterial supply resource, material resource | THIS RESOURCE IS NO LONGER IN SERVICE, documented on October 6, 2011. A project to collect, store and study DNA samples from tens of thousands of healthy volunteers and patients with diseases of major public importance. It aims to identify genes that are risk factors for the conditions. The network consists of 13 collections led by different clinicians throughout the UK. At its heart is an archive infrastructure which manages the DNA and the information associated with it. The European Collection of Cell Cultures in Porton Down handles the blood, peripheral blood lymphocytes and EBV-transformed cell lines, while the Centre for Integrated Genomic Medical Research at Manchester University manages the DNA. These banked samples are available to UK and international researchers, who can examine data and set up collaborative work by registering at the DNA Network's website. The conditions for which samples are currently collected and stored are: Acute leukemia, Asthma and eczema, Late onset Alzheimer's disease, Breast cancer, Colorectal cancer, Coronary artery disease, Glomerulonephritis, Hypertension, Age-related macular degeneration, Multiple sclerosis, Parkinson's disease, Type 2 diabetes, Unipolar depression. | alzheimer, gene, dna, peripheral blood lymphocyte, ebv-transformed cell line |
is listed by: One Mind Biospecimen Bank Listing has parent organization: University of Manchester; Manchester; United Kingdom |
Leukemia, Asthma, Eczema, Alzheimer's disease, Breast cancer, Colorectal cancer, Coronary artery disease, Glomerulonephritis, Hypertension, Age-related macular degeneration, Multiple Sclerosis, Parkinson's disease, Type 2 diabetes, Unipolar depression, Cancer | MRC | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_60877 | SCR_010619 | SciCrunch Registry | 2026-10-17 01:34:45 | 3 | ||||||
|
Biological Resource Centre - National Institute for Cancer Research Resource Report Resource Website 1+ mentions |
Biological Resource Centre - National Institute for Cancer Research (RRID:SCR_010548) | CRB-IST | biomaterial supply resource, material resource | The Centro di Risorse Biologiche (CRB-IST), institutional facility of IST, has been recently established by the General Director (Deliberation number 624 July 11, 2008). It aims at co-ordinating already existing biobanking activities, and participating in the European Infrastructure of Biobanks and Biomolecular Resources (BBMRI), in preparation in the frame of the 7th FP of the European Community. Aims: * to facilitate high quality translational research dependent on biological material and data * to address ethical issues on biobanking * to promote the project at the population level * to co-ordinate the IST biobanks and cell banks * to harmonize technical and management SOPs, according to international best practices * to help reduce costs for collection and storage of biological material * to favor institutional recognition at a regional, national and international level - to sustain the role of the Institute in the European infrastructure. | cancer, serum, plasma, frozen, formalin-fixed paraffin-embedded |
is listed by: One Mind Biospecimen Bank Listing is related to: Biobanking and Biomolecular Resources Research Infrastructure (BBMRI) has parent organization: IST National Institute for Cancer Research; Genoa; Italy |
Cancer | Public | nlx_31955 | SCR_010548 | SciCrunch Registry | Centro di Risorse Biologiche - istituto nazionale per la ricerca sul cancro, Centro di Risorse Biologiche - IST | 2026-10-17 01:34:08 | 5 | ||||||
|
UCL Biobank Resource Report Resource Website |
UCL Biobank (RRID:SCR_000517) | UCL Biobank | biomaterial supply resource, material resource | Two University College London (UCL) biobanks, one based at the Royal Free Hospital (RFH) Campus and the other based at Bloomsbury supporting Pathology and the Cancer Institute, will act as physical repositories for collections of biological samples and data from patients consented at UCLH, Partners Hospitals and external sources. This will incorporate collections of existing stored samples and new collections. UCL-RFH BioBank, the physical repository at the Royal Free, presents a unique opportunity to advance medical research through making access to research tissue easier, faster and much more efficient. The BioBank is both a physical repository, with capacity for up to 1 million cryogenically stored samples and a virtual repository for all tissue, cell, plasma, serum, DNA and RNA samples stored throughout UCLP. In particular, samples considered "relevant material", such as tissues and cells, that are licensed by the Human Tissue Authority, can be stored long term. Existing holdings of tissues and cells where appropriate can be transferred to the Physical BioBank at the Royal Free. UCL - Royal Free BioBank provides a flexible approach to banking, allowing the Depositor to pick and choose services that are tailored to fit their requirements. Collaborations arising from publicizing of the existence of the holdings are entirely at the discretion of the depositor, as the facility ensures that access to the deposits remains at the decision of the Depositor/User. UCL Biobank for studying Health and Disease (based at Pathology-Rockefeller building and the UCL-Cancer Institute will support projects principally involved in the study of human disease. The aim is to support primarily, research in the Pathology Department, UCLH and the UCL-Cancer Institute but it will also support other UCLH partners. The biobank will store normal and pathological specimens, surplus to diagnostic requirements, from relevant tissues and bodily fluids. Stored tissues will include; snap-frozen or cryopreserved tissue, formalin-fixed tissue, paraffin-embedded tissues, and slides prepared for histological examination. Tissues will include resection specimens obtained surgically or by needle core biopsy. Bodily fluids will include; whole blood, serum, plasma, urine, cerebrospinal fluid, milk, saliva and buccal smears and cytological specimens such as sputum and cervical smears. Fine needle aspirates obtained from tissues and bodily cavities (e.g. pleura and peritoneum) will also be collected. Where appropriate the biobank will also store separated cells, protein, DNA and RNA isolated from collected tissues and bodily fluids described above. Some of the tissue and aspirated samples will be stored in the diagnostic archive. | tissue, cell, plasma, serum, dna, rna, blood, serum, plasma, urine, cerebral spinal fluid, milk, saliva, buccal smear, sputum, cervical smear, pleura, peritoneum, protein, body fluid, cryopreserved, frozen, snap-frozen, formalin-fixed, paraffin-embedded, slide, cancer, disease, normal |
is listed by: One Mind Biospecimen Bank Listing has parent organization: University College London; London; United Kingdom |
Cancer, Disease, Normal | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_36620 | SCR_000517 | SciCrunch Registry | Biobanking at UCL | 2026-10-17 01:34:23 | 0 | ||||||
|
The Cancer Genome Atlas Resource Report Resource Website 5000+ mentions |
The Cancer Genome Atlas (RRID:SCR_003193) | TCGA | biomaterial supply resource, material resource | Project exploring the spectrum of genomic changes involved in more than 20 types of human cancer that provides a platform for researchers to search, download, and analyze data sets generated. As a pilot project it confirmed that an atlas of changes could be created for specific cancer types. It also showed that a national network of research and technology teams working on distinct but related projects could pool the results of their efforts, create an economy of scale and develop an infrastructure for making the data publicly accessible. Its success committed resources to collect and characterize more than 20 additional tumor types. Components of the TCGA Research Network: * Biospecimen Core Resource (BCR); Tissue samples are carefully cataloged, processed, checked for quality and stored, complete with important medical information about the patient. * Genome Characterization Centers (GCCs); Several technologies will be used to analyze genomic changes involved in cancer. The genomic changes that are identified will be further studied by the Genome Sequencing Centers. * Genome Sequencing Centers (GSCs); High-throughput Genome Sequencing Centers will identify the changes in DNA sequences that are associated with specific types of cancer. * Proteome Characterization Centers (PCCs); The centers, a component of NCI's Clinical Proteomic Tumor Analysis Consortium, will ascertain and analyze the total proteomic content of a subset of TCGA samples. * Data Coordinating Center (DCC); The information that is generated by TCGA will be centrally managed at the DCC and entered into the TCGA Data Portal and Cancer Genomics Hub as it becomes available. Centralization of data facilitates data transfer between the network and the research community, and makes data analysis more efficient. The DCC manages the TCGA Data Portal. * Cancer Genomics Hub (CGHub); Lower level sequence data will be deposited into a secure repository. This database stores cancer genome sequences and alignments. * Genome Data Analysis Centers (GDACs) - Immense amounts of data from array and second-generation sequencing technologies must be integrated across thousands of samples. These centers will provide novel informatics tools to the entire research community to facilitate broader use of TCGA data. TCGA is actively developing a network of collaborators who are able to provide samples that are collected retrospectively (tissues that had already been collected and stored) or prospectively (tissues that will be collected in the future). | genome, genome sequencing, breast, central nervous system, endocrine, gastrointestinal, gynecologic, head, neck, hematologic, skin, soft tissue, thoracic, urologic, clinical, genomic characterization, analysis, tumor genome, demographic, gene expression, copy number alteration, epigenetic, dna sequence, exome, snp, methylation, mrna, mirna, FASEB list |
is used by: Mutation Annotation and Genomic Interpretation is used by: BioXpress is used by: cancerRxTissue is listed by: One Mind Biospecimen Bank Listing is related to: Cancer3D is related to: Cancer Research Data Commons is related to: CancerMIRNome is related to: Broad Institute Genomics Platform has parent organization: National Cancer Institute works with: FireBrowse |
Cancer, Tumor, Normal, Breast cancer, Central Nervous System cancer, Endocrine cancer, Gastrointestinal cancer, Gynecologic cancer, Head cancer, Neck cancer, Hematologic cancer, Skin cancer, Soft tissue cancer, Thoracic cancer, Urologic cancer | NCI 261200800001E-12-0-1 | nlx_156913 | SCR_003193 | SciCrunch Registry | Cancer Genome Atlas | 2026-10-17 01:33:47 | 7443 | ||||||
|
e-Driver Resource Report Resource Website 1+ mentions |
e-Driver (RRID:SCR_002674) | software application, software resource, standalone software | Software tool to identify cancer driver genes based on linear annotations of biological regions such as protein domains.Uses information on three-dimensional structures of mutated proteins to identify specific structural features. Then algorithm analyzes whether these features are enriched in cancer somatic mutations and are candidate driver genes. | Identify cancer driver genes, candidate driver genes, perl, protein, mutated proteins, cancer somatic mutations, bio.tools |
is listed by: OMICtools is listed by: Debian is listed by: bio.tools |
Cancer | PMID:25064568 | Free, Available for download, Freely available | biotools:e-Driver, OMICS_05288 | https://bio.tools/e-Driver | SCR_002674 | SciCrunch Registry | 2026-10-17 01:33:50 | 5 | ||||||
|
Pleiades Promoter Project: Genomic Resources Advancing Therapies for Brain Disorders Resource Report Resource Website 1+ mentions |
Pleiades Promoter Project: Genomic Resources Advancing Therapies for Brain Disorders (RRID:SCR_003282) | Pleiades Promoter Project | biomaterial supply resource, material resource | Project to generate human DNA promoters of less than 4 kb (MiniPromoters) to drive gene expression in defined brain regions of therapeutic interest for diseases such as Alzheimer, Parkinson, Huntington, Amyotrophic Lateral Sclerosis, Multiple Sclerosis, Spinocerebellar Ataxia, Depression, Autism, and Cancer. Project develops and shares tools like human MiniPromoters that drive region- and cell-specific gene expression in the mouse brain, expression constructs, mouse embryonic stem cell lines, and knock-in mice all of which carry brain-specific MiniPromoters. Project is daughter of Genome Canada Project, Atlas of Gene Expression in Mouse Development, within which mouse brain gene expression data have already been gathered. Project team has collaborated with International BioPharma Solutions Ltd., management and communications consulting company specializing in product development and commercialization advice. Project will explore challenging interface between science and journalism with focus on genomics and gene therapy. | Human, DNA, promoter, gene, expression, brain, disorder, therapy |
is listed by: One Mind Biospecimen Bank Listing is related to: CanEuCre is related to: JAX Cre Repository is related to: Recombinase (cre) Activity has parent organization: University of British Columbia; British Columbia; Canada |
Alzheimer, Parkinson, Huntington, Amyotrophic Lateral Sclerosis, Multiple Sclerosis, Spinocerebellar Ataxia, Depression, Autism, Cancer | Child and Family Research Institute ; Genome British Columbia ; Genome Canada ; UBC Institute of Mental Health |
Free, Freely available | nif-0000-01868 | https://plone.bcgsc.ca/project/pleiades-promoter-project | http://www.pleiades.org/ | SCR_003282 | SciCrunch Registry | 2026-10-17 01:33:47 | 4 | ||||
|
Karolisnka Biobank Resource Report Resource Website |
Karolisnka Biobank (RRID:SCR_004355) | KI Biobank | biomaterial supply resource, material resource | KI Biobank is an accredited core facility offering sample collection services. KI Biobank is located at the Department of Medical Epidemiology and Biostatistics. KI Biobank offer infrastructure for pre analytical sample handling and provide researchers guidance on how samples should be taken and labeled. The processes comprise registration, handling, storage and distribution of samples. KI Biobank also offers DNA-extraction from blood and saliva. In order to insure complete traceability on samples and belonging information all processes are controlled by a Laboratory Information Management System (LIMS). For every new study a contract is established describing the study and the disposition rights. We also help in writing Biobank agreements including multicenteravtal and Material Transfer Agreement. KI Biobank is, according to the Biobank law, responsible for all sample collections handled within the core facility and those that are stored on the departments on KI campus. Clinical sample collections are handled by the Biobank units at the respective hospitals within the Stockholm County Council. Besides the samples that are stored centrally at KI Biobank, KI Biobank is also the administrative biobank for research sample collections at Karolinska Institutet that are stored and administrated at the departments. All research sample collections must be reported to KI Biobank. The following types of sample collections are registered in the biobank; sample collections taken within the regular health care that has been transferred to Karolinska Institutet with an agreement of transfer, samples taken from healthy individuals or other persons out of the regular health care and samples that have been taken abroad. | asthma, lung disease, cancer, cardiac disease, multiple sclerosis, ms, neurological disease, neurological injury, psychiatric disease, twin, dna-extraction |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Karolinska Institute; Stockholm; Sweden is parent organization of: KI Biobank - Amphetamine dependence is parent organization of: KI Biobank - PAIN is parent organization of: PRACSIS - Prognosis and Risk in Acute Coronary Syndromes In Sweden is parent organization of: KI Biobank is parent organization of: KI Biobank - KOL is parent organization of: KI Biobank - SCI is parent organization of: KI Biobank - GEMS is parent organization of: KI Biobank - TBI is parent organization of: KI Biobank - EIMS is parent organization of: KI Biobank - IMSE is parent organization of: KI Biobank - BROAD is parent organization of: KI Biobank - SBP is parent organization of: KI Biobank STAGE-ADHD is parent organization of: KI Biobank - STANLEY is parent organization of: KI Biobank - STAR is parent organization of: KI Biobank - EuroClot is parent organization of: KI Biobank - Economical Behavior is parent organization of: CATSS - Child and Adolescent Twin Study in Sweden is parent organization of: KI Biobank - SATSA is parent organization of: KI Biobank - SALTY is parent organization of: KI Biobank - STAGE is parent organization of: KI Biobank - TwinGene is parent organization of: BIOAIR - BIOmarkers in severe Chronic AIRway Disease is parent organization of: KI Biobank - NOAK is parent organization of: OLIN - Obstructive Lung disease in Northern Sweden is parent organization of: Cancer of the Prostate in Sweden (CAPS) is parent organization of: KI Biobank - CEFALO is parent organization of: ICAP - Integrated analysis of prostate cancer is parent organization of: LIBRO-1: Individualized prediction and prevention of breast cancer is parent organization of: KI Biobank - PROCAP is parent organization of: SCALE - Scandinavian lymphoma etiology is parent organization of: SPSAC - Stockholm PSA Cohort is parent organization of: KI Biobank - Tissue Biobank is parent organization of: KI Biobank - CEFAM is parent organization of: KI Biobank - PAROKRANK is parent organization of: KI Biobank - Sodertaljehjartan is parent organization of: KI Biobank - Parkinson is parent organization of: KI Biobank - EXT is parent organization of: KI Biobank - ALF is parent organization of: KI Biobank - HARMONY is parent organization of: Twin Study of Child and Adolescent Development - TCHAD is parent organization of: SHEEP - Stockholm Heart Epidemiology Program |
Asthma, Lung disease, Cancer, Cardiac disease, Multiple Sclerosis, Neurological disease, Neurological injury, Mental disease, Healthy, Normal control, Twin, Late adult human | nlx_37545 | http://ki.se/ki/jsp/polopoly.jsp?d=9620&l=en | SCR_004355 | SciCrunch Registry | Karolinska Institutet Biobank | 2026-10-17 01:33:49 | 0 | ||||||
|
Swedish Regional Biobank Resource Report Resource Website |
Swedish Regional Biobank (RRID:SCR_004503) | Swedish RBC | biomaterial supply resource, material resource | To meet the law requirements and regulations of the National Board of the Southern Health Care Region, Region Skane and Lund University agreed to establish a common biobanking center for Southern healthcare region. Regional biobanksrcentrum will develop and maintain systems for quality assurance and integrity protected using biobanks. The Regional Biobank center is responsible for matters relating to the collection, storage and use of samples stored in biobanks in the Southern healthcare region. Regional Biobank center operations consist of: * to promote the use of biobank material is in accordance with legal requirements biobank * to promote integrity protected and safe storage of repository material * to provide information about the biobank law and biobank materials used for individual sample donors, health professionals, researchers and the public * to handle requests for modified consent and desire to destroy or de test * maintaining a current and privacy protected records of repository material in the region * work to the individual''s integrity will be strengthened in relation to research on biobank material. Tissue samples available to other parties, by surrendering, or by sending tissue samples for analysis, requiring the return or destruction, after completion of the analysis. Regional Biobank Centre (RBC) for the southern healthcare region was established in 2004 and was until 2010 in the Oncology Centre. As of January 1, 2011 it is under the management of RBC Labmedicin Skane. | tissue, bodily fluid |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Lund University; Lund; Sweden |
Cancer, Birth defect, Chromosomal abnormality | Application forms should be used by researchers who want access to samples from health care research. The form contains two parts: I. Application for establishment of and access to samples. II. Agreement on release of samples and personal data. | nlx_48758 | SCR_004503 | SciCrunch Registry | Swedish Regional Biobank Center Southern Health Care Region, Swedish Regional Biobank Center, Regional Biobank Centre Southern Health Care Region, RBC Southern Health Care Region | 2026-10-17 01:34:29 | 0 | ||||||
|
Janus Serum Bank Resource Report Resource Website 1+ mentions |
Janus Serum Bank (RRID:SCR_005885) | Janus Serum Bank | biomaterial supply resource, material resource | The Janus Serum Bank has blood samles from 317 000 Norwegians. The biobank is reserved for cancer research, and is internationally unique regarding size and number of cancer cases. The Janus Serum Bank is a population based biobank reserved for cancer research. The specimens are collected during the period from 1972-2004 and are stored at 25 degrees Celsius. The samples originate from 317 000 persons in Norway who have participated in health studies and also from blood donors in and around Oslo. Today, samples are only collected from earlier donors in the Janus Serum Bank who have developed cancer. The Bank is internationally unique regarding size and number of cancer cases. Annual linkage to the Cancer Registry shows that 52 500 donors are diagnosed with cancer as of December 31, 2009. The main goals of the biobank are to make the material available to cancer researchers over the whole world and deliver quality assured samples and data. The Janus Serum Bank is registered in the Biobank Register (Notification number 737) | blood, cancer |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Cancer Registry of Norway |
Cancer | Public: The main goals of the biobank are to make the material available to cancer researchers over the whole world and deliver quality assured samples and data. | nlx_149448 | SCR_005885 | SciCrunch Registry | Janus serumbank | 2026-10-17 01:33:56 | 1 | ||||||
|
Cancer Control using Population-based Registries and Biobanks Resource Report Resource Website |
Cancer Control using Population-based Registries and Biobanks (RRID:SCR_004902) | CCPRB | biomaterial supply resource, material resource | CCPRB (Cancer Control using Population-based Registries and Biobanks) is a Network of Excellence project within the sixth framework programme of the European Union. It is aiming at improved control of cancer by facilitating research linking biobanks and cancer registries. The project involves a systematic quality assurance and continuous development of standards and norms for human sample biobanks in Europe, as well as development of improved integrity-protection standards in the handling of sensitive information in connection with biobank-based research. The samples in the biobanks will be used in large-scale cancer research searching for genetic and infectious causes to cancer, in particular in the areas of breast and colorectal cancer and childhood leukemia. Project objectives: * Provide the study base for uniquely large population-based prospective studies on cancer * Define and implement a generally applicable European Quality Standard for Biobanking that will include improved data and specimen standardization, acquisition and analysis, reliable and standardized statistical analysis as well as improved management and co-ordination of European biobanks. * Define and promote the implementation of integrity-proof methods for biobank-based research involving well defined and secure third party code-keeping systems. * Enable large-scale, population-based research on: ** evaluation of cancer treatment and role of molecular markers in treatment selection ** use over-generation registry linkages applied to large biobank cohorts to identify and evaluate genetic predisposition associated with increased cancer risk as well as interactions with common environmental exposures. ** use over-generation registry linkages applied to large biobank cohorts to explore and evaluate intrauterine exposures associated with increased cancer risk ** exploit the power of large population cohorts for design of optimal strategies for cancer prevention and its evaluation. * Establish a Europe-wide network for spreading the awareness of i) the data, samples and knowledge generated European biobank-based research ii) possibilities for future biobank-based research and iii) the best practice quality standards for biobank-based research. | genetic, infectious disease, young human, child, registry, biobank |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Lund University; Lund; Sweden |
Cancer, Breast cancer, Colorectal cancer, Childhood leukemia, Leukemia | European Union FP6 | nlx_87258 | SCR_004902 | SciCrunch Registry | CCPRB (Cancer Control using Population-based Registries and Biobanks), Cancer Control using Population-based Registries Biobanks, CCPRB (Cancer Control using Population-based Registries Biobanks), CCPRB - Cancer Control using Population-based Registries and Biobanks | 2026-10-17 01:33:50 | 0 | ||||||
|
American College of Surgeons National Cancer Database Resource Report Resource Website 10+ mentions |
American College of Surgeons National Cancer Database (RRID:SCR_025488) | NCDB | data or information resource, database | Clinical oncology database sourced from hospital registry data collected in Commission on Cancer-accredited facilities. These data are used to analyze and track patients with malignant neoplastic diseases, their treatments, and outcomes. | Commission on Cancer-accredited facilities, hospital registry data, malignant neoplastic diseases, | cancer, malignant neoplastic, | Free, Freely available, | SCR_025488 | SciCrunch Registry | 2026-10-17 01:38:54 | 27 | |||||||||
|
NCI Division of Cancer Control and Population Sciences SEER-Medicare Linked Data Resource Resource Report Resource Website 10+ mentions |
NCI Division of Cancer Control and Population Sciences SEER-Medicare Linked Data Resource (RRID:SCR_025811) | data or information resource, disease-related portal, portal, topical portal | Portal to reflect the linkage of two large population based sources of data that provide detailed information about Medicare beneficiaries with cancer. | NCI, Medicare beneficiaries with cancer, Medicare beneficiaries data, cancer data, |
is related to: Surveillance Epidemiology and End Results has parent organization: National Cancer Institute |
cancer | Free, Freely available, | SCR_025811 | SciCrunch Registry | SEER-Medicare Linked Data Resource | 2026-10-17 01:36:52 | 14 | ||||||||
|
OncoTree Resource Report Resource Website 10+ mentions |
OncoTree (RRID:SCR_026218) | data or information resource, disease-related portal, portal, topical portal | Community-driven cancer classification platform encompassing rare and common cancers that provides clinically relevant and appropriately granular cancer classification for clinical decision support systems and oncology research. Cancer classification system for precision oncology. | cancer classification platform, rare and common cancers, cancer classification, precision oncology, | cancer | NCI P30 CA008748 | PMID:33625877 | Free, Freely available | SCR_026218 | SciCrunch Registry | 2026-10-17 01:37:02 | 20 | ||||||||
|
NIH NCI Cancer Data Access System Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Portal Resource Report Resource Website 1+ mentions |
NIH NCI Cancer Data Access System Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Portal (RRID:SCR_028226) | data or information resource, disease-related portal, portal, topical portal | National Cancer Institute (NCI)-sponsored randomized, controlled study (1993–2001) of ~155,000 adults aged 55-74 to evaluated whether organized, regular screenings could reduce cancer deaths compared to usual care. Portal provides randomized, controlled trial data used to determine whether certain screening exams reduce mortality from prostate, lung, colorectal and ovarian cancer. | randomized, controlled trial, screening exams, reduce mortality, prostate, lung, colorectal, ovarian, cancer | Cancer | Restricted | SCR_028226 | SciCrunch Registry | Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, Prostate | 2026-10-17 01:38:37 | 8 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the NIF Resources search. From here you can search through a compilation of resources used by NIF and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that NIF has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on NIF then you can log in from here to get additional features in NIF such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into NIF you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
Welcome to the Neuroscience Information Framework Project, designed to serve the biomedical research community. NIF maintains the largest searchable collection of neuroscience data, the largest catalog of biomedical resources, and the largest ontology for neuroscience on the web. We welcome all feedback and suggestions and are actively looking for resource providers to make their resources accessible through NIF. Learn about the tools available to help you share your data and discover a dynamic inventory of Web-based neuroscience resources.
